Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141475 |
| CAS No | NA |
| Mol.F. | C16H19FN4O5 |
| Mol.Wt. | 366.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141476 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O6S |
| Mol.Wt. | 428.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141477 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O4S |
| Mol.Wt. | 396.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141478 |
| CAS No | NA |
| Mol.F. | C8H5F2N3O2S |
| Mol.Wt. | 245.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141479 |
| CAS No | NA |
| Mol.F. | C32H27F4N7O9S2 |
| Mol.Wt. | 793.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141480 |
| CAS No | NA |
| Mol.F. | C32H26F4N8O10S2 |
| Mol.Wt. | 822.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141481 |
| CAS No | NA |
| Mol.F. | C16H19ClN2O3 |
| Mol.Wt. | 322.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141482 |
| CAS No | NA |
| Mol.F. | C24H29N9O2 |
| Mol.Wt. | 475.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141483 |
| CAS No | NA |
| Mol.F. | C23H27N9O2 |
| Mol.Wt. | 461.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141484 |
| CAS No | NA |
| Mol.F. | C15H18Cl2N4O3 |
| Mol.Wt. | 373.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141485 |
| CAS No | NA |
| Mol.F. | C12H12N4O3S |
| Mol.Wt. | 292.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141486 |
| CAS No | NA |
| Mol.F. | C13H10N4O4S |
| Mol.Wt. | 318.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141487 |
| CAS No | NA |
| Mol.F. | C15H17N5O4S |
| Mol.Wt. | 363.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141488 |
| CAS No | NA |
| Mol.F. | C17H21N5O4S |
| Mol.Wt. | 391.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141489 |
| CAS No | NA |
| Mol.F. | C15H16N4O5S |
| Mol.Wt. | 364.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141490 |
| CAS No | NA |
| Mol.F. | C12H10N2O2 |
| Mol.Wt. | 214.2 |
| INV STATUS | CUSTOM SYNTHESIS |